Search Results - "Byrtus, H"

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre-screening of 5-HT1A ligands by Zajdel, PaweŁ, Bojarski, Andrzej J., Byrtus, Hanna, ChŁoń-Rzepa, Grażyna, Obniska, Jolanta, Chevallet, Pierre, Martinez, Jean, PawŁowski, Maciej

    Published in Biomedical chromatography (01-07-2003)
    “…Chromatographic parameters (ΔRf), defined as a difference in the migration of tested compound on the control and peptide impregnated silica gel TLC plates,…”
    Get full text
    Journal Article
  2. 2

    Synthesis and pharmacological evaluation of novel N-Mannich bases derived from 5,5-diphenyl and 5,5-di(propan-2-yl)imidazolidine-2,4-dione core by Czopek, Anna, Byrtus, Hanna, Zagórska, Agnieszka, Rychtyk, Joanna, Góra, Małgorzata, Sałat, Kinga, Rapacz, Anna, Obniska, Jolanta

    Published in Bioorganic & medicinal chemistry letters (15-08-2019)
    “…[Display omitted] The aim of this study was to design and synthesize two series of N-Mannich bases with imidazolidine-2,4-dione core as a potential…”
    Get full text
    Journal Article
  3. 3

    Synthesis and antiarrhythmic properties of basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione II by Kieć-Kononowicz, K, Byrtus, H, Zejc, A, Filipek, B, Chevallet, P

    Published in Farmaco (Società chimica italiana : 1989) (01-05-1995)
    “…Basic amide derivatives of imidazolidine-2,4-dione and pyrrolidine-2,5-dione were synthesized as potential antiarrhythmic agents. Some of them have shown…”
    Get more information
    Journal Article
  4. 4
  5. 5

    Preliminary study on application of impregnated synthetic peptide TLC stationary phases for the pre-screening of 5-HT sub(1A) ligands by Zajdel, P, Bojarski, A J, Byrtus, H, Chon-Rzepa, G, Obniska, J, Chevallet, P, Martinez, J, Pawowski, M

    Published in Biomedical chromatography (01-01-2003)
    “…Chromatographic parameters ([Delta]R sub(f)), defined as a difference in the migration of tested compound on the control and peptide impregnated silica gel TLC…”
    Get full text
    Journal Article
  6. 6

    Structure-Activity Relationship of Some New Anti-Arrhythmic Phenytoin Derivatives by Ciechanowicz-Rutkowska, Maria, Stadnicka, Katarzyna, Kiec-Kononowicz, Katarzyna, Byrtus, Hanna, Filipek, Barbara, Zygmunt, Malgorzata, Macia̧g, Dorota

    Published in Archiv der Pharmazie (Weinheim) (01-11-2000)
    “…The pharmacological activity of nine anti‐arrhythmic phenytoin derivatives was assessed in preventing chloroform‐induced arrhythmia. The compounds were tested…”
    Get full text
    Journal Article
  7. 7

    3-(omega-Aminoalkyl)-5,5-dialkyl(or spirocycloalkyl-1',5-)hydantoins as new 5-HT1A and 5-HT2A receptor ligands by Byrtus, H, Pawłowski, M, Charakchieva-Minol, S, Duszyńska, B, Mokrosz, M J, Mokrosz, J L, Zejc, A

    Published in Archiv der Pharmazie (Weinheim) (01-06-1996)
    “…A series of new 3-(omega-aminoalkyl)-5,5-disubstituted hydantoins, containing 1-phenylpiperazine, 1-(o-methoxyphenyl)piperazine or…”
    Get more information
    Journal Article
  8. 8

    Arylpiperazine derivatives of 3-propyl-beta-tetralonohydantoin as new 5-HT1A and 5-HT2A receptor ligands by Byrtus, H, Pawłowski, M, Duszyńska, B, Wesołowska, A, Chojnacka-Wójcik, E, Bojarski, A J

    Published in Polish journal of pharmacology (01-07-2001)
    “…A series of new analogues of 3-[3-(4-arylpiperazinyl)-propyl]-cyclo-hexane-1',5-spirohydantoin (2), with aromatic ring fused in amide moiety (4-9) were…”
    Get full text
    Journal Article
  9. 9